Industries
Regenerative Medicine
Regenerative medicine replaces or repairs damaged tissues using scaffolds, cells, and growth factors. Academic biomaterials and stem cell groups are key IP sources for decellularized ECM products, injectable hydrogels, and organoid platforms that companies license for wound care, orthopedics, and organ repair applications.
Details
- Companies
- MiMedxOrganogenesisSmith and Nephew Advanced WoundIntegra LifeSciencesAnika TherapeuticsLifecell KCICook BiotechNuo TherapeuticsBioTissueAcelity
- Market Size
- $26B
- Target Researchers
- Tissue engineers, biomaterials scientists, and cell biologists specializing in scaffold fabrication, organ-on-chip systems, decellularized ECM, 3D bioprinting, and stem cell differentiation into tissue-specific lineages
- Use Cases
- Biomaterial scaffold licensingOrganoid model co-development3D bioprinting platform partnershipsECM-derived product supplyWound healing biology researchStem cell differentiation protocol transfer